JPWO2023174175A5 - - Google Patents

Info

Publication number
JPWO2023174175A5
JPWO2023174175A5 JP2024554912A JP2024554912A JPWO2023174175A5 JP WO2023174175 A5 JPWO2023174175 A5 JP WO2023174175A5 JP 2024554912 A JP2024554912 A JP 2024554912A JP 2024554912 A JP2024554912 A JP 2024554912A JP WO2023174175 A5 JPWO2023174175 A5 JP WO2023174175A5
Authority
JP
Japan
Prior art keywords
hydrocarbyl
membered
general formula
optionally substituted
halohydrocarbyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024554912A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025508192A5 (https=
JP2025508192A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/080775 external-priority patent/WO2023174175A1/zh
Publication of JP2025508192A publication Critical patent/JP2025508192A/ja
Publication of JP2025508192A5 publication Critical patent/JP2025508192A5/ja
Publication of JPWO2023174175A5 publication Critical patent/JPWO2023174175A5/ja
Pending legal-status Critical Current

Links

JP2024554912A 2022-03-17 2023-03-10 Ｋｉｆ１８ａ阻害剤 Pending JP2025508192A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202210266719 2022-03-17
CN202210266719.4 2022-03-17
PCT/CN2023/080775 WO2023174175A1 (zh) 2022-03-17 2023-03-10 Kif18a抑制剂

Publications (3)

Publication Number Publication Date
JP2025508192A JP2025508192A (ja) 2025-03-21
JP2025508192A5 JP2025508192A5 (https=) 2026-03-18
JPWO2023174175A5 true JPWO2023174175A5 (https=) 2026-03-18

Family

ID=88022235

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024554912A Pending JP2025508192A (ja) 2022-03-17 2023-03-10 Ｋｉｆ１８ａ阻害剤

Country Status (7)

Country Link
US (1) US20250197382A1 (https=)
EP (1) EP4495113A4 (https=)
JP (1) JP2025508192A (https=)
CN (1) CN118613478A (https=)
AU (1) AU2023236101A1 (https=)
CA (1) CA3246028A1 (https=)
WO (1) WO2023174175A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250027560A (ko) * 2022-06-30 2025-02-26 쑤저우 젠하우스 바이오 컴퍼니 리미티드 질소 함유 화합물 및 이의 용도
WO2024022508A1 (zh) * 2022-07-29 2024-02-01 武汉人福创新药物研发中心有限公司 Kif18a抑制剂及用途
TW202416973A (zh) 2022-08-18 2024-05-01 美商雅客森醫療公司 Ｋｉｆ１８ａ抑制劑及其用途
EP4567032A4 (en) * 2022-09-08 2025-11-05 Changchun Genescience Pharmaceutical Co Ltd KIF18A INHIBITOR COMPOUND, PHARMACEUTICAL COMPOSITION AND ITS PREPARATION AND USE
CN119907796A (zh) * 2022-09-09 2025-04-29 海南先声再明医药股份有限公司 酰胺类化合物、其组合物及用途
WO2024067465A1 (zh) * 2022-09-30 2024-04-04 山东轩竹医药科技有限公司 Kif18a抑制剂
CN117917405A (zh) * 2022-10-21 2024-04-23 杭州邦顺制药有限公司 Kif18a蛋白抑制剂
CN120265620A (zh) * 2022-11-24 2025-07-04 益方生物科技(上海)股份有限公司 杂环化合物、其制备方法和用途
EP4628486A1 (en) * 2022-12-02 2025-10-08 Shenzhen Zhongge Biological Technology Co., Ltd. Amide or urea compound
WO2024125626A1 (en) * 2022-12-16 2024-06-20 Nuphase Therapeutics (Hangzhou) Limited., Co. Nitrogenous compound, pharmaceutical composition and use thereof
CN120752230A (zh) * 2022-12-28 2025-10-03 英矽智能科技知识产权有限公司 Kif18a的抑制剂及其用途
CN120418237A (zh) * 2023-01-09 2025-08-01 浙江海正药业股份有限公司 芳香酰胺类衍生物及其制备方法和用途
WO2024188086A1 (zh) * 2023-03-10 2024-09-19 浙江海正药业股份有限公司 芳香酰胺类衍生物及其制备方法和用途
CN121002013A (zh) * 2023-04-18 2025-11-21 南京同诺康医药科技有限公司 Kif18a抑制剂及其制备方法和用途
TW202545925A (zh) * 2024-02-06 2025-12-01 大陸商上海齊魯製藥研究中心有限公司 螺環kif18a抑制劑
WO2025190364A1 (zh) * 2024-03-14 2025-09-18 山东轩竹医药科技有限公司 Kif18a抑制剂及其用途
WO2025201531A1 (zh) * 2024-03-29 2025-10-02 深圳众格生物科技有限公司 三环类化合物及其用途
WO2025242166A1 (en) * 2024-05-22 2025-11-27 InventisBio Co., Ltd. Heterocyclic compounds, preparation methods and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020132651A1 (en) * 2018-12-20 2020-06-25 Amgen Inc. Kif18a inhibitors
TWI844602B (zh) * 2018-12-20 2024-06-11 美商安進公司 Kif18a抑制劑
JP7676308B2 (ja) * 2018-12-20 2025-05-14 アムジエン・インコーポレーテツド Ｋｉｆ１８ａ阻害剤として有用なヘテロアリールアミド
US12540129B2 (en) * 2019-08-02 2026-02-03 Amgen Inc. KIF18A inhibitors
AU2020326627B2 (en) * 2019-08-02 2026-01-29 Amgen Inc. KIF18A inhibitors
WO2021026099A1 (en) * 2019-08-02 2021-02-11 Amgen Inc. Kif18a inhibitors
JP2023521802A (ja) * 2020-04-14 2023-05-25 アムジエン・インコーポレーテツド 新生物疾患の処置のためのｋｉｆ１８ａ阻害剤
CN119212988A (zh) * 2022-05-13 2024-12-27 上海湃隆生物科技有限公司 驱动蛋白kif18a抑制剂及其应用

Similar Documents

Publication Publication Date Title
JPWO2023174175A5 (https=)
KR102244937B1 (ko) 글리옥사미드 치환된 피롤아미드 유도체 및 ｂ형 간염 치료용 의약으로서의 이의 용도
JPWO2021092115A5 (https=)
AU2005202964B2 (en) Pharmaceutically active isoindoline derivatives
CA2850166C (en) Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer
JP2019536785A5 (https=)
JP2021514001A5 (https=)
EP1240160A1 (en) Substituted pyridazines having cytokine inhibitory activity
AR054787A1 (es) Derivados de piperidinas utiles como antagonistas de histamina h3
RU2009119290A (ru) Производные гидантоина, используемые в качестве ингибиторов ммр
JP2016500661A5 (https=)
JP2021522262A5 (https=)
JP2017526614A5 (https=)
JP2005513125A5 (https=)
JP2009532417A5 (https=)
JP2021528405A5 (https=)
JP2014500322A5 (https=)
RU2002133208A (ru) Замещенные 1-аминоалкиллактамы и их применение в качестве антагонистов мускариновых рецепторов
JP2019501927A5 (https=)
JP2019151624A (ja) 飽和環縮合ジヒドロピリミジノン又はジヒドロトリアジノン化合物及びその医薬用途
JPWO2022256434A5 (https=)
JPWO2023016434A5 (https=)
RU2019109570A (ru) 8-(азетидин-1-ил)-[1,2,4]триазоло[1,5-а]пиридинилы, композиции и способы их применения
HRP20201402T1 (hr) Spojevi inhibitora acetilkolinsteraze i agonisti serotonergičkih receptora 5ht4, s promnezijskim učinkom, postupci za njihovu pripremu i farmaceutski pripravci koji ih sadržavaju
JPWO2019213470A5 (https=)